Invention Grant
- Patent Title: Immunoconjugates targeting CD46 and methods of use thereof
-
Application No.: US17395358Application Date: 2021-08-05
-
Publication No.: US11484604B2Publication Date: 2022-11-01
- Inventor: Marc Nasoff , Andrew Dorr
- Applicant: Fortis Therapeutics, Inc.
- Applicant Address: US CA La Jolla
- Assignee: Fortis Therapeutics, Inc.
- Current Assignee: Fortis Therapeutics, Inc.
- Current Assignee Address: US CA La Jolla
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K47/68 ; A61K47/26 ; C07K16/30
Abstract:
Disclosed herein are immunoconjugates comprising a CD46 binding domain and effector agent. Further provided herein are methods of treating cancer comprising administering to a subject having cancer a pharmaceutical composition comprising immunoconjugates comprising a CD46 binding domain and effector agent.
Information query
